• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病伴发痴呆与阿尔茨海默病之间的神经精神差异

Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease.

作者信息

Aarsland D, Cummings J L, Larsen J P

机构信息

Section of Geriatric Psychiatry, Rogaland Psychiatric Hospital, PO 1163 Hillevåg, 4095 Stavanger, Norway.

出版信息

Int J Geriatr Psychiatry. 2001 Feb;16(2):184-91. doi: 10.1002/1099-1166(200102)16:2<184::aid-gps304>3.0.co;2-k.

DOI:10.1002/1099-1166(200102)16:2<184::aid-gps304>3.0.co;2-k
PMID:11241724
Abstract

OBJECTIVE

To compare the profile of neuropsychiatric symptoms in patients with Parkinson's disease with dementia (PDD) and patients with Alzheimer's disease (AD).

DESIGN

Cross-sectional survey of a population-based sample of patients with PDD and AD patients matched for age, sex, and Mini-Mental State Examination (MMSE) score.

METHOD

Patients were diagnosed according to published criteria for PD and AD. The diagnosis of dementia in PD was made according to DSM-III-R, and was based on clinical interview of the patient and a relative, psychometric testing (including MMSE, Dementia Rating Scale and tests assessing memory, executive functions and visuospatial functioning) and physical examination. The Neuropsychiatric Inventory (NPI) was administered to all patients.

RESULTS

One or more psychiatric symptoms was reported in 95% of AD and 83% of PDD patients. Hallucinations were more severe in PD patients, while aberrant motor behavior, agitation, disinhibition, irritability, euphoria, and apathy were more severe in AD. In PDD, apathy was more common in mild Hoehn and Yahr stages, while delusions increased with more severe motor and cognitive disturbances. In PDD, only delusions correlated with the MMSE score.

CONCLUSIONS

Neuropsychiatric symptoms are common and severe in patients with PDD, with important implications for the management of these patients. AD and PDD patients have different neuropsychiatric profiles, suggesting different underlying mechanisms. Cognitive impairment, psychopathology, and motor features progress independently in PDD patients

摘要

目的

比较帕金森病痴呆(PDD)患者与阿尔茨海默病(AD)患者的神经精神症状特征。

设计

对基于人群的PDD患者样本和年龄、性别及简易精神状态检查表(MMSE)评分相匹配的AD患者进行横断面调查。

方法

根据已发表的PD和AD诊断标准对患者进行诊断。PD患者的痴呆诊断依据《精神疾病诊断与统计手册》第三版修订本(DSM-III-R),基于对患者及其亲属的临床访谈、心理测量测试(包括MMSE、痴呆评定量表以及评估记忆、执行功能和视空间功能的测试)和体格检查。对所有患者使用神经精神科问卷(NPI)进行评估。

结果

95%的AD患者和83%的PDD患者报告有一项或多项精神症状。幻觉在PD患者中更为严重,而异常运动行为、激越、脱抑制、易激惹、欣快和淡漠在AD患者中更为严重。在PDD中,淡漠在轻度Hoehn和Yahr分期中更为常见,而妄想则随着运动和认知障碍的加重而增加。在PDD中,只有妄想与MMSE评分相关。

结论

神经精神症状在PDD患者中常见且严重,对这些患者的管理具有重要意义。AD和PDD患者具有不同的神经精神特征,提示潜在机制不同。PDD患者的认知障碍、精神病理学和运动特征独立进展。

相似文献

1
Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease.帕金森病伴发痴呆与阿尔茨海默病之间的神经精神差异
Int J Geriatr Psychiatry. 2001 Feb;16(2):184-91. doi: 10.1002/1099-1166(200102)16:2<184::aid-gps304>3.0.co;2-k.
2
[Comparison of cognitive functions and neuropsychiatric symptoms between patients with Parkinson's disease dementia and Alzheimer's disease].帕金森病痴呆患者与阿尔茨海默病患者认知功能及神经精神症状的比较
Zhonghua Yi Xue Za Zhi. 2013 Aug 20;93(31):2459-62.
3
Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.帕金森病痴呆、路易体痴呆和阿尔茨海默病患者的神经精神症状和 α-突触核蛋白特征。
J Neurol. 2018 Oct;265(10):2295-2301. doi: 10.1007/s00415-018-8992-7. Epub 2018 Aug 6.
4
Neuropsychiatric Symptoms in Parkinson's Disease Dementia Are More Similar to Alzheimer's Disease than Dementia with Lewy Bodies: A Case-Control Study.帕金森病痴呆的神经精神症状与阿尔茨海默病比路易体痴呆更相似:一项病例对照研究。
PLoS One. 2016 Apr 21;11(4):e0153989. doi: 10.1371/journal.pone.0153989. eCollection 2016.
5
Apathy and related executive syndromes in dementia associated with Parkinson's disease and in Alzheimer's disease.帕金森病相关痴呆和阿尔茨海默病相关痴呆中的淡漠及相关执行综合征。
Behav Neurol. 2013 Jan 1;27(4):515-22. doi: 10.3233/BEN-129023.
6
Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress.帕金森病合并痴呆患者的神经精神症状:发生率、特征及相关的照料者压力
J Neurol Neurosurg Psychiatry. 2007 Jan;78(1):36-42. doi: 10.1136/jnnp.2005.083113. Epub 2006 Jul 4.
7
Instrumental activities of daily living in Parkinson's disease dementia as compared with Alzheimer's disease: relationship to motor disability and cognitive deficits: a pilot study.帕金森病痴呆与阿尔茨海默病患者的日常生活活动能力评估:与运动障碍和认知缺陷的关系:一项初步研究。
J Neurol Sci. 2011 Nov 15;310(1-2):279-82. doi: 10.1016/j.jns.2011.07.048. Epub 2011 Aug 17.
8
The association between cognitive impairment and neuropsychiatric symptoms in patients with Parkinson's disease dementia.帕金森病痴呆患者认知障碍与神经精神症状的关系。
Int Psychogeriatr. 2012 Dec;24(12):1980-7. doi: 10.1017/S1041610212001317. Epub 2012 Jul 27.
9
[Comparison of naming impairment among patients with Parkinson's disease without dementia, Parkinson's disease dementia and Alzheimer's disease].[帕金森病非痴呆患者、帕金森病痴呆患者与阿尔茨海默病患者命名障碍的比较]
Zhonghua Yi Xue Za Zhi. 2016 Jun 7;96(21):1664-7. doi: 10.3760/cma.j.issn.0376-2491.2016.21.010.
10
[Characterisation and prevalence of the psychological and behavioural symptoms in patients with dementia].[痴呆患者心理和行为症状的特征及患病率]
Rev Neurol. 2007;45(11):683-8.

引用本文的文献

1
Comparison of the Effectiveness of Transcranial Direct Current Stimulation (tDCS) and Short-Term Cognitive Rehabilitation Protocols on the Improvement of Depression and Anxiety Symptoms in Patients With Mild Alzheimer's Disease.经颅直流电刺激(tDCS)与短期认知康复方案对改善轻度阿尔茨海默病患者抑郁和焦虑症状的有效性比较
J Aging Res. 2025 Jul 29;2025:6616509. doi: 10.1155/jare/6616509. eCollection 2025.
2
The prevalence of apathy in Lewy body dementia: A systematic review and meta-analysis.路易体痴呆中淡漠的患病率:一项系统评价和荟萃分析。
Alzheimers Dement. 2025 Jul;21(7):e70425. doi: 10.1002/alz.70425.
3
Systems biology approach discovers comorbidity interaction of Parkinson's disease with psychiatric disorders utilizing brain transcriptome.
系统生物学方法利用大脑转录组发现帕金森病与精神障碍的共病相互作用。
Front Mol Neurosci. 2023 Aug 16;16:1232805. doi: 10.3389/fnmol.2023.1232805. eCollection 2023.
4
A Preliminary Comparison of the Methylome and Transcriptome from the Prefrontal Cortex Across Alzheimer's Disease and Lewy Body Dementia.阿尔茨海默病和路易体痴呆患者前额叶皮质甲基化组与转录组的初步比较
J Alzheimers Dis Rep. 2023 Apr 20;7(1):279-297. doi: 10.3233/ADR220114. eCollection 2023.
5
Prevalence and Risk Factors of Neuropsychiatric Symptoms in Institutionalized Patients with Parkinson's Disease in Taiwan: A Nationwide Observational Study.台湾帕金森病住院患者神经精神症状的患病率及危险因素:一项全国性观察性研究
Healthcare (Basel). 2023 Jan 13;11(2):258. doi: 10.3390/healthcare11020258.
6
Diagnosis and management of Parkinson's disease dementia and dementia with Lewy bodies: recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology.帕金森病痴呆和路易体痴呆的诊断与管理:巴西神经病学学会认知神经病学与衰老科学部的建议
Dement Neuropsychol. 2022 Nov 28;16(3 Suppl 1):73-87. doi: 10.1590/1980-5764-DN-2022-S105PT. eCollection 2022 Sep.
7
Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep-Wake Cycle Disorder.重新审视几种组胺H3受体拮抗剂/反向激动剂在认知障碍、焦虑、抑郁和睡眠-觉醒周期紊乱方面的临床前观察结果。
Front Pharmacol. 2022 Jun 1;13:861094. doi: 10.3389/fphar.2022.861094. eCollection 2022.
8
Association Between BDNF Val66Met Polymorphism and Mild Behavioral Impairment in Patients With Parkinson's Disease.脑源性神经营养因子Val66Met多态性与帕金森病患者轻度行为障碍之间的关联
Front Neurol. 2021 Jan 14;11:587992. doi: 10.3389/fneur.2020.587992. eCollection 2020.
9
The Prevalence and Determinants of Neuropsychiatric Symptoms in Late-Stage Parkinsonism.晚期帕金森病中神经精神症状的患病率及决定因素
Mov Disord Clin Pract. 2020 May 21;7(5):531-542. doi: 10.1002/mdc3.12968. eCollection 2020 Jul.
10
Management of psychiatric disorders in Parkinson's disease : Neurotherapeutics - Movement Disorders Therapeutics.帕金森病相关精神障碍的治疗:神经治疗学-运动障碍治疗学。
Neurotherapeutics. 2020 Oct;17(4):1511-1524. doi: 10.1007/s13311-020-00875-w.